- Home
- LEGT vs NYXH Comparison
LEGT vs NYXH Comparison
Compare LEGT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGT
- NYXH
- Stock Information
- Founded
- LEGT 2023
- NYXH 2009
- Country
- LEGT United States
- NYXH Belgium
- Employees
- LEGT N/A
- NYXH N/A
- Industry
- LEGT
- NYXH Medical/Dental Instruments
- Sector
- LEGT
- NYXH Health Care
- Exchange
- LEGT Nasdaq
- NYXH Nasdaq
- Market Cap
- LEGT 265.3M
- NYXH 261.1M
- IPO Year
- LEGT 2024
- NYXH 2021
- Fundamental
- Price
- LEGT $10.29
- NYXH $8.28
- Analyst Decision
- LEGT
- NYXH Strong Buy
- Analyst Count
- LEGT 0
- NYXH 5
- Target Price
- LEGT N/A
- NYXH $17.00
- AVG Volume (30 Days)
- LEGT 37.0K
- NYXH 27.0K
- Earning Date
- LEGT 01-01-0001
- NYXH 11-06-2024
- Dividend Yield
- LEGT N/A
- NYXH N/A
- EPS Growth
- LEGT N/A
- NYXH N/A
- EPS
- LEGT N/A
- NYXH N/A
- Revenue
- LEGT N/A
- NYXH $5,668,079.00
- Revenue This Year
- LEGT N/A
- NYXH $37.10
- Revenue Next Year
- LEGT N/A
- NYXH $418.12
- P/E Ratio
- LEGT N/A
- NYXH N/A
- Revenue Growth
- LEGT N/A
- NYXH 32.65
- 52 Week Low
- LEGT $10.00
- NYXH $4.00
- 52 Week High
- LEGT $10.47
- NYXH $20.00
- Technical
- Relative Strength Index (RSI)
- LEGT N/A
- NYXH 33.81
- Support Level
- LEGT N/A
- NYXH $8.02
- Resistance Level
- LEGT N/A
- NYXH $10.01
- Average True Range (ATR)
- LEGT 0.00
- NYXH 0.48
- MACD
- LEGT 0.00
- NYXH -0.15
- Stochastic Oscillator
- LEGT 0.00
- NYXH 13.07
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About NYXH Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.